The Psychedelic Investment Index is an online tool that tracks the “entire public sector of the psychedelic market, ”representing over forty companies and their market trends at the time...
Mycotopia Therapies, a company focused on psychedelic therapy, has recently announced the formation of ‘PsyBioMed-Australia,’ a joint venture between itself and Natural MedTech. Through a formal letter of intent,...
Vancouver-based clinical-stage pharmaceutical company Algernon Pharmaceuticals was recently added to the Horizons Psychedelic Stock Index ETF (PSYK) in the index’s first quarterly rebalance of holdings for 2021. PSYK is...
German biotech company Atai Life Sciences is all set to become one of the first licensed producers of psilocybin and other psychoactive medicinal substances in the U.S. Atai aims...
Canada's booming cannabis and psychedelic market are starting to make waves across the border. With the SAFE law about to be implemented, it is now easier for psychedelic medicine...
Toronto-based company Red Light Holland announced on March 19th, 2021, that its wholly-owned subsidiary, RLH Netherlands B.V. has successfully purchased SR Wholesale B.V., "one of the Netherlands' premiere distributors...
Bloom Burton Securities Inc. conducted the Offering (the "Lead Underwriter"), as lead underwriter and sole bookrunner with Stifel GMP and Canaccord Genuity Corp., forming a syndicate of underwriters (together...
According to a survey, which the World Health Organisation (WHO) conducted between June to August 2020 across 130 countries, over 60% of the countries reported disruptions to critical mental...
Ehave, Inc. (OTC Pink: EHVVF), a leader in the research and distribution of novel therapeutics, has reached a new milestone this January 4th. The Company has applied to upgrade...
